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The Editorial on the Research Topic
Protein Solubility and Aggregation in Bacteria
For many years, the aggregation of proteins and polypeptides remained a neglected area of protein
chemistry. It was only with the discovery that the insoluble deposits found in the organs and tissues
of patients suffering from different diseases were enriched in a single, but different polypeptide, that
the interest in understanding how and why these proteins aggregate arose (Fernàndez-Busquets
et al., 2008). From that time on, the study of protein aggregation has evolved to become a key
research topic, whose implications span disciplines like biochemistry, biomedicine, biotechnology,
and nanotechnology.
The formation of insoluble protein aggregates is linked to more than 40 human diseases
(Invernizzi et al., 2012). In all these disorders, the aggregated proteins assemble into a common
β-sheet enriched supra-molecular structure, known as amyloid. A large number of higher
eukaryotic biochemical pathways, from DNA replication to protein degradation, have been
modeled first in prokaryotic organisms, providing important clues on the molecular basis of
pathology (Dwyer et al., 2012). Scientists have long known that, very often, the heterologous
expression of proteins in bacteria results in the accumulation of the target protein in insoluble
deposits. However, only recently a number of laboratories have dared to exploit this well-
characterized phenomenon to dissect the determinants of protein aggregation into amyloid
assemblies (Villar-Pique and Ventura, 2012). Bacteria posses an intracellular environment that,
while differing from that of eukaryotic cells, is physiologically more relevant than a test tube.
Accordingly, they constitute privileged model systems to understand the mechanisms behind
amyloid assembly and the cellular fitness cost associated with the formation of these aggregates
(Navarro et al., 2014), but also to screen for effective modulators of amyloid aggregation with
potential therapeutic applications (Villar-Piqué et al., 2012).
Protein aggregation constitutes a major bottleneck in the biotechnological production of protein
based therapeutics. Consequently, a large effort has been devoted to the development of orthogonal
strategies to increase soluble protein yields, including in vitro protein synthesis (Ventura, 2005).
Bacterial extracts have become a convenient means to produce recombinant proteins in vitro,
because they contain all the machinery required for protein synthesis. This technology has
rendered a significant volume of data on the behavior of proteins during their cell-free synthesis.
As illustrated by Tokmakov, these datasets can be exploited to derive the physicochemical
and structural properties associated with the solubility and aggregation of eukaryotic proteins
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(Tokmakov). However, the cell is a very crowded environment
and during cell-free experiments the concentration of cellular
components is significantly diluted, questioning whether these
assays recapitulate intracellular conditions. To address this
question, the group of Taguchi has made an effort to synthetize
more than 100 proteins in a bacterial cell-free system, either in
the absence or in the presence of specific crowding agents. Their
results demonstrate that the impact of crowding on aggregation
is not generic, but protein-dependent (Niwa et al.).
Protein aggregates are not distributed homogeneously in the
cytoplasm of bacteria, instead, they are mainly located at one
or at the two poles of the organism. This localization has
important functional consequences, from regulating signaling
to protect the rest of the cell from misfolded species. In an
original study, Emberly and co-workers from Simon Fraser
University demonstrated that the localization of aggregating
proteins in bacteria depends on their expression rates. This
suggests that the localization of protein aggregates is constrained
by aggregation itself, but also by nucleoid occlusion (Scheu et al.).
When the accumulation of these polar aggregates results from
the recombinant protein expression, they are named inclusion
bodies (IBs). Despite they contain certain impurities, IBs are
usually highly enriched in the target polypeptide. This property,
together with their insolubility, allows for an easy purification of
the recombinant polypeptide. In many cases, the protein can be
recovered afterwards in its biologically active form upon in vitro
unfolding and subsequent refolding, as demonstrated by the
group of Panda for L-asparaginase (Upadhyay et al.).
Molecular chaperones, like trigger factor, the Dna KJE system
and GroEL/GroES survey the protein quality in the bacterial
cytosol. However, a dedicated mechanism is needed when
proteins should be targeted to the bacterial membrane. Genevaux
and co-workers from Université Paul Sabatier review the crucial
role played by multitasking Sec B chaperones in this complex
process (Sala et al.). Chaperones regulate proteostasis, but they
also may allow the apparition of novel beneficial phenotypes.
In this way, the Thomas Bentin’s group demonstrates how
GroEL/GroES over-expression increases cellular fitness and
expands the mutational space. These effects provide an
opportunity for bacteria to acquire tolerance, and even resistance,
to antibiotics (Goltermann et al.).
Accumulating evidence indicates that different organisms
exploit the special architecture of amyloid protein aggregates for
functional purposes (Otzen, 2010). Functional bacterial amyloids
constitute amazing macromolecular systems, where shifts in the
folding and solubility of the embedded proteins in response to
environmental factors critically affect activity, as reviewed by
Boles and co-workers at University of Iowa (Syed and Boles).
Two nice examples of the role played by these functional
assemblies are provided in the works of Otzen’s group and
Lagos lab. In the first case, the authors described how amyloids
in the Pseudomonas biofilm make a major contribution to the
mechanical robustness of this extracellular matrix (Zeng et al.).
In the second example, the authors identify the key residues
accounting for the amyloid propensity of MccE492, a pore-
forming bacteriocin whose antibacterial activity seems to be
inactivated in the aggregated state (Aguilera et al.).
Prions are a special class of amyloids, in which the aggregated
state becomes self-perpetuating. The prion phenomenon is best-
known by its association with encephalopathies in mammals,
but it also occurs in lower eukaryotic organisms, like yeast,
where it is exploited for functional purposes. The self-assembly
of yeast prions relies on the presence of long and intrinsically
disordered glutamine/asparagine rich domains. These domains
are both necessary and sufficient for self-templating protein
aggregation. Giraldo and his group, showed that a fragment
of these domains could be replaced by the protein sequence
of RepA-WH1, a bacterial protein with amyloid-like properties,
without losing the intracellular aggregation potential of the
resulting chimera in yeast (Gasset-Rosa and Giraldo). This
finding opens up the possibility that prion-like proteins would
also exist in prokaryotes. Accordingly, the group of Ventura,
using a previously developed computational approach (Espinosa
Angarica et al., 2014), identified more than 2000 putative prion
candidates in bacterial proteomes (Iglesias et al.). A significant
number of these proteins are involved in DNA transcription
and protein translation, therefore, playing a crucial role in the
regulation of biochemical pathways. One outstanding example
of this type of proteins is the Rho terminator factor. Ventura
and co-workers demonstrate that in the pathogen Clostridium
Botulinum this essential protein contains a prion-like domain,
with the ability to self-assemble into amyloid structures similar
to those found in yeast prions (Pallares et al.).
Overall, it is clear that the study of protein solubility and
aggregation in bacteria is a highly dynamic field with the potential
to provide very relevant insights and tools to understand and
control deleterious and beneficial protein self-assembly.
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